about
Fluorescent and Bioluminescent Reporter MyxovirusesEfficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals.Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.RNA virus reverse genetics and vaccine design.Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screeningNipah virus uses leukocytes for efficient dissemination within a host.Hendra and nipah infection: pathology, models and potential therapies.Heparan sulfate-dependent enhancement of henipavirus infection.The immunomodulating V and W proteins of Nipah virus determine disease course.Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.Optimized P2A for reporter gene insertion into Nipah virus results in efficient ribosomal skipping and wild-type lethalityStudies on the paramyxovirus accessory genes by reverse genetics in the Sendai virus-mouse system.Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets.HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases.Targeted strategies for henipavirus therapeuticsParamyxoviruses infecting humans: the old, the new and the unknown.Efficient and Robust Paramyxoviridae Reverse Genetics Systems.Henipavirus receptor usage and tropism.Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsHenipavirus Encephalitis: Recent Developments and Advances.Determination of a phosphorylation site in Nipah virus nucleoprotein and its involvement in virus transcriptionNovel phosphoprotein-interacting region in Nipah virus nucleocapsid protein and its involvement in viral replication.An improved reverse genetics system for mammalian orthoreovirusesEstablishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.Eukaryotic elongation factor 1-beta interacts with the 5' untranslated region of the M gene of Nipah virus to promote mRNA translation.Downregulation of Nipah virus N mRNA occurs through interaction between its 3' untranslated region and hnRNP D.Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usageDifferential rates of protein folding and cellular trafficking for the Hendra virus F and G proteins: implications for F-G complex formation.Type I interferon signaling protects mice from lethal henipavirus infection.Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds.Possible role of the Nipah virus V protein in the regulation of the interferon beta induction by interacting with UBX domain-containing protein1.Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.
P2860
Q26741398-DECEBA10-A95D-4FD5-B16F-8102B21E6D19Q30368610-96C421F7-6122-41BC-A695-38EBA567CCEEQ30989497-4444CDB0-234D-494F-AFDF-BAE58920F0EBQ33508793-86400949-7EA1-48AB-9F14-40EE892D8BC8Q33963398-450F24EC-FCF5-4FD7-9BF1-B68C94770DD5Q34456557-5BC4C355-2B62-4E2A-9398-044B4682602BQ34629595-81D5F516-64FE-428B-BD47-4C54AE4B734FQ35134796-47F4B17F-4FFB-4906-837F-108A4DFECE36Q35140337-E653E1FD-2077-4753-98ED-1F94775B9B22Q35658146-11F3BFB7-2D5C-43B2-B042-723CE9050F44Q35677600-AE28A9A2-D63F-436F-957F-E5E12BCD39E3Q35785921-5DA35469-D6F0-4270-8AC7-3E202EB3E5A3Q36276572-848D73A3-4A94-4347-9E11-DB46E87194D9Q36862277-0D1032CF-B555-4D87-B3C1-8728BD8E3594Q37038283-A4BB1C4A-3E08-406A-A420-8B258238328AQ37047905-D6F37B81-EAEA-43D3-828E-00A415F227F8Q37093466-835F6A3E-7308-4D81-A8DC-27C4F83CC396Q37175177-6E02B0A9-E3A0-449B-ACCE-A88CA13F7F67Q37506512-F3B97CBC-343C-4D03-B114-0D02F4A25700Q37727631-297BB140-3ADF-4608-9EA8-27D5A950DBE2Q38018531-4C948B52-81BD-4FA1-B959-2E878015A257Q38363535-18B67090-F179-4575-B1F7-E5AD9976A92DQ38567114-38F67E5F-723E-4620-B5D5-4AC1F4801C4DQ39536393-27A14721-75A7-44A1-B4AB-EDEC4287C7EBQ39674259-5B7E231D-1778-4958-BC0F-8FDA11990136Q39757270-DB0B56DE-59CA-43DC-A2F8-CE4F47F68599Q40074669-247429B6-AD3D-4FDF-B1B5-19048B83ECCEQ40730514-014ADF47-3095-4813-9128-3F5EA6E1E47AQ41880090-DB20D8A8-B6F5-42C0-8E41-751CA929F420Q42282103-1B445B24-DD6A-48AD-A91F-B1DAA6D0A273Q42546299-89AF3A3C-119A-4E7C-B0D0-20CEBEB0AD7EQ48325941-205FBCEB-D2DC-4DF1-9763-4C934BE24695Q52664407-73974C8E-62A9-4FD2-8CC2-2FC5D9413642Q54974477-87BA547C-007A-482B-9502-D47C81209E32Q55132682-5226F679-70FF-4DA8-969E-189D5A18D13F
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Establishment of a Nipah virus rescue system.
@ast
Establishment of a Nipah virus rescue system.
@en
type
label
Establishment of a Nipah virus rescue system.
@ast
Establishment of a Nipah virus rescue system.
@en
altLabel
Establishment of a Nipah virus rescue system
@en
prefLabel
Establishment of a Nipah virus rescue system.
@ast
Establishment of a Nipah virus rescue system.
@en
P2093
P2860
P356
P1476
Establishment of a Nipah virus rescue system.
@en
P2093
Chieko Kai
Fusako Ikeda
Hiroki Sato
Misako Yoneda
T Fabian Wild
Vanessa Guillaume
Yuki Sakuma
P2860
P304
16508-16513
P356
10.1073/PNAS.0606972103
P407
P577
2006-10-19T00:00:00Z